Zenken Corporation will issue 1,000 stock acquisition rights, corresponding to 100,000 shares, with an exercise price of 803 yen. The exercise period is from 2027-10-01 to 2036-10-28. The exercisable ratio will increase stepwise upon achievement of performance targets. Expected shareholder dilution is equivalent to 0.82%. Various provisions include adjustments for stock splits, consolidations, and corporate reorganizations.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7371","jir_company_name":"Zenken Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-29","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/7371-20260929-02.pdf","jir_short_summary":"Zenken Corporation will issue 1,000 stock acquisition rights, corresponding to 100,000 shares, with an exercise price of 803 yen. The exercise period is from 2027-10-01 to 2036-10-28. The exercisable ratio will increase stepwise upon achievement of performance targets. Expected shareholder dilution is equivalent to 0.82%. Various provisions include adjustments for stock splits, consolidations, and corporate reorganizations.","jir_summary":"### Overview of Issuance of Stock Acquisition Rights\nZenken Corporation resolved to issue 1,000 paid stock acquisition rights to directors. The granted shares total 100,000 shares and the exercise price is 803 yen. The exercise period is from 2027-10-01 to 2036-10-28, and several conditions are specified, including adjustment provisions for stock splits and consolidations and limits on capital increase amounts upon share issuance. The dilution is expected to be equivalent to 0.82% of the total issued shares.\n\n### Exercise Conditions, Risks and Future Procedures\nExercise of the stock acquisition rights is conditioned on exceeding certain levels of operating income, allowing phased exercisability, with exercisable ratios varying according to performance levels from the fiscal period ending June 2027 onward. Detailed rules regarding non-exercisability by heirs, transfer restrictions, and treatment in corporate reorganizations are listed concerning exercise, succession, and adjustment of rights.","jir_financial_highlights":"Number of stock acquisition rights: 1,000 pieces (Unknown)\nGranted shares: 100,000 shares (Unknown)\nExercise price: 803 yen (Unknown)\nExercise period: 2027-10-01\u301c2036-10-28 (Unknown)\nPlanned dilution ratio: 0.82% of total issued shares (Unknown)","jir_category":"","jir_hashtags":"#ZenkenStockOptions, #StockAcquisitionRights, #StockOptions","jir_key_figures":"Number of stock acquisition rights: 1,000 pieces\nGranted shares: 100,000 shares\nExercise price: 803 yen\nExercise period of stock acquisition rights: 2027\/10\/1 - 2036\/10\/28\nPlanned dilution ratio: 0.82%","jir_meta_title":"Zenken Corporation: Resolution to Issue Stock Acquisition Rights\uff5cSeptember 29, 2026","jir_meta_description":"Zenken Corporation will issue 1,000 paid stock acquisition rights to directors. Granted shares total 100,000 shares, exercise price is 803 yen, and the exercise period is 2027-10-01 to 2036-10-28. Expected dilution is 0.82%. See the full notice for details.","jir_og_title":"Zenken Corporation\uff5cResolution to Issue Stock Acquisition Rights","jir_og_description":"Zenken Corporation to issue stock acquisition rights: 100,000 granted shares, exercise price 803 yen, exercise period 2027\u20132036. Expected dilution: 0.82%.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":122848,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-124440","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n